$13.5 Billion is the total value of ALPS ADVISORS INC's 892 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| S | Exit | SPRINT CORP | $0 | – | -12,010 | -100.0% | 0.00% | – |
| GNW | Exit | GENWORTH FINANCI | $0 | – | -15,317 | -100.0% | 0.00% | – |
| ENT | Exit | GLOBAL EAGLE ENT | $0 | – | -33,086 | -100.0% | 0.00% | – |
| CZR | Exit | CAESARS ENTERTAI | $0 | – | -11,470 | -100.0% | -0.00% | – |
| NOK | Exit | NOKIA CORP-ADR | $0 | – | -12,639 | -100.0% | -0.00% | – |
| SIRI | Exit | SIRIUS XM HOLDIN | $0 | – | -12,441 | -100.0% | -0.00% | – |
| ODP | Exit | OFFICE DEPOT INC | $0 | – | -32,736 | -100.0% | -0.00% | – |
| AVP | Exit | AVON PRODUCTS | $0 | – | -46,285 | -100.0% | -0.00% | – |
| GRPN | Exit | GROUPON INC | $0 | – | -23,948 | -100.0% | -0.00% | – |
| HIW | Exit | HIGHWOODS PROP | $0 | – | -5,798 | -100.0% | -0.00% | – |
| GSV | Exit | GOLD STANDARD VE | $0 | – | -218,770 | -100.0% | -0.00% | – |
| STMP | Exit | STAMPS.COM INC | $0 | – | -4,499 | -100.0% | -0.00% | – |
| ADMS | Exit | ADAMAS PHARMACEU | $0 | – | -66,026 | -100.0% | -0.00% | – |
| SYBX | Exit | SYNLOGIC INC | $0 | – | -61,466 | -100.0% | -0.00% | – |
| ABUS | Exit | ARBUTUS BIOPHARM | $0 | – | -134,053 | -100.0% | -0.00% | – |
| GPRE | Exit | GREEN PLAINS INC | $0 | – | -31,421 | -100.0% | -0.00% | – |
| TOCA | Exit | TOCAGEN INC | $0 | – | -55,440 | -100.0% | -0.00% | – |
| NCS | Exit | NCI BUILDING SYS | $0 | – | -96,387 | -100.0% | -0.00% | – |
| BAK | Exit | BRASKEM SA-ADR | $0 | – | -22,764 | -100.0% | -0.00% | – |
| MEIP | Exit | MEI PHARMA INC | $0 | – | -171,852 | -100.0% | -0.00% | – |
| NPK | Exit | NATL PRESTO INDS | $0 | – | -5,825 | -100.0% | -0.00% | – |
| CALA | Exit | CALITHERA BIOSCI | $0 | – | -92,089 | -100.0% | -0.00% | – |
| ELLI | Exit | ELLIE MAE INC | $0 | – | -5,278 | -100.0% | -0.00% | – |
| SYRS | Exit | SYROS PHARMACEUT | $0 | – | -81,287 | -100.0% | -0.01% | – |
| CASI | Exit | CASI PHARMACEUTI | $0 | – | -230,154 | -100.0% | -0.01% | – |
| DSW | Exit | DSW INC-CL A | $0 | – | -28,884 | -100.0% | -0.01% | – |
| SAIC | Exit | SCIENCE APPLICAT | $0 | – | -10,157 | -100.0% | -0.01% | – |
| ABEO | Exit | ABEONA THERAPEUT | $0 | – | -115,800 | -100.0% | -0.01% | – |
| FPRX | Exit | FIVE PRIME THERA | $0 | – | -85,663 | -100.0% | -0.01% | – |
| FLXN | Exit | FLEXION THERAPEU | $0 | – | -91,439 | -100.0% | -0.01% | – |
| CPRX | Exit | CATALYST PHARMAC | $0 | – | -248,154 | -100.0% | -0.01% | – |
| LTC | Exit | LTC PROPERTIES | $0 | – | -40,394 | -100.0% | -0.01% | – |
| AKBA | Exit | AKEBIA THERAPEUT | $0 | – | -282,329 | -100.0% | -0.02% | – |
| ATRA | Exit | ATARA BIOTHERAPE | $0 | – | -110,257 | -100.0% | -0.03% | – |
| CRSP | Exit | CRISPR THERAPEUT | $0 | – | -125,116 | -100.0% | -0.03% | – |
| PAAS | Exit | PAN AMER SILVER | $0 | – | -398,874 | -100.0% | -0.04% | – |
| INSM | Exit | INSMED INC | $0 | – | -187,286 | -100.0% | -0.04% | – |
| ASND | Exit | ASCENDIS PHA-ADR | $0 | – | -70,468 | -100.0% | -0.06% | – |
| ARRY | Exit | ARRAY BIOPHARMA | $0 | – | -382,739 | -100.0% | -0.07% | – |
| GLPG | Exit | GALAPAGOS NV-ADR | $0 | – | -87,116 | -100.0% | -0.07% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Red Rocks Capital LLC #1
- Morningstar Investment Management LLC #2
- Rocky Mountain Advisers, LLC #3
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-07
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENTERPRISE PRODUCTS PARTNERS L | 42 | Q3 2023 | 8.6% |
| PLAINS ALL AMER PIPELINE LP | 42 | Q3 2023 | 8.5% |
| NuStar LP MLP | 42 | Q3 2023 | 2.9% |
| Genesis Energy MLP | 42 | Q3 2023 | 2.7% |
| Vgrd Total Bond Mkt ETF | 42 | Q3 2023 | 1.4% |
| Vgrd MSCI EAFE ETF | 42 | Q3 2023 | 1.0% |
| PFIZER INC | 42 | Q3 2023 | 0.8% |
| VERIZON COMMUNICATIONS INC | 42 | Q3 2023 | 0.6% |
| Vgrd FTSE Emerge Mkt ETF | 42 | Q3 2023 | 0.5% |
| AT&T INC | 42 | Q3 2023 | 0.4% |
View ALPS ADVISORS INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Crestwood Equity Partners LP | February 13, 2023 | 12,335,027 | 11.8% |
| DCP Midstream, LP | February 13, 2023 | 13,458,511 | 6.5% |
| HOLLY ENERGY PARTNERS LP | February 13, 2023 | 6,821,862 | 5.4% |
| Magellan Midstream Partners, L.P. | February 13, 2023 | 13,179,330 | 6.4% |
| EnLink Midstream, LLC | February 09, 2021 | 33,136,669 | 6.0% |
| NGL Energy Partners LP | February 09, 2021 | 25,376,955 | 11.7% |
| TC PIPELINES LP | February 09, 2021 | 6,072,740 | 8.5% |
| Western Midstream Operating, LP | February 09, 2021 | 24,153,629 | 6.1% |
| EnLink Midstream, LLC | February 07, 2020 | 31,194,714 | 6.3% |
| Shell Midstream Partners, L.P. | February 07, 2020 | 14,825,754 | 6.4% |
View ALPS ADVISORS INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G/A | 2024-02-05 |
| SC 13G | 2024-02-05 |
| SC 13G | 2024-02-05 |
| SC 13G | 2024-02-05 |
View ALPS ADVISORS INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.